Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Pericardial effusion

Cardiology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Suspected tamponade with worsening perfusion is an obstructive-shock emergency. Call cardiology, critical care and a drainage-capable team, perform immediate focused echocardiography and arrange urgent image-guided or surgical decompression according to cause and anatomy. Do not delay definitive source control for CT, complete blood results or fluid aetiology testing in a deteriorating patient.

Synopsis

Assess why pericardial fluid has accumulated, define its size and trajectory, recognise tamponade physiology, choose observation, diagnostic sampling or drainage, and coordinate cause-specific care for malignant, purulent and recurrent effusions.

  • An effusion is a finding, not a diagnosis. Establish the clinical context, likely cause, echo size, haemodynamic effect and whether the volume is stable, enlarging or recurring.
  • Slow accumulation may permit a very large effusion without shock; rapid bleeding can produce tamponade with a much smaller echo measurement.
  • TTE should describe distribution, end-diastolic separation, chamber interaction, respiratory Doppler changes, IVC response, ventricular function and comparison with prior studies.
  • Tamponade is a clinical-haemodynamic diagnosis. Tachycardia, raised JVP, pulsus paradoxus and impaired perfusion matter more than the presence or absence of the complete Beck triad.
  • Drain urgently for haemodynamic compromise. Drain or obtain tissue for suspected purulent, tuberculous or malignant disease when the result and source control will alter treatment, even if classic tamponade is absent.
  • A symptomatic, enlarging, recurrent or loculated effusion needs specialist review for catheter drainage, surgical window, biopsy or other cause-directed intervention.
  • Isolated non-inflammatory fluid should not be treated automatically with aspirin, an NSAID, colchicine or corticosteroid. Use the dedicated Acute pericarditis and Recurrent pericarditis chapters when active inflammatory pericarditis is present.
  • After drainage, track output and re-accumulation, send a complete targeted specimen set and document who will act on culture, cytology and biopsy results.

Key red flags

Evolving tamponade

Progressive dyspnoea, tachycardia, raised JVP, narrow pulse pressure, pulsus paradoxus, cool peripheries, oliguria, confusion or rising lactate indicates impaired filling and falling output.

Rapid haemopericardium

Collapse after an invasive cardiac procedure, penetrating or blunt trauma, suspected type A aortic dissection or myocardial rupture may occur before the effusion appears large. Clot and loculation can make standard echo views misleading.

Purulent disease

Fever, toxicity, bacteraemia, pneumonia or empyema, recent thoracic surgery, immunosuppression or a neutrophilic fluid appearance raises concern for bacterial infection and demands urgent drainage and antimicrobial source control.

Investigation priorities

01
Transthoracic echocardiographyFirst step

Confirm fluid, measure the largest end-diastolic separation in standard views, define circumferential versus loculated distribution and assess haemodynamic effects.

Management branches

AssessDefine cause, physiology and trajectory

A new or previously documented pericardial effusion is identified.

  1. Assess symptoms, pulse, blood pressure, JVP, perfusion, pulsus paradoxus when appropriate and any precipitating procedure, trauma, infection, renal failure, thyroid disease, autoimmune disease or cancer.
  2. Obtain TTE and compare with every available prior study. Document distribution, measured size, chamber interaction, respiratory Doppler findings, IVC and ventricular function.
  3. Use baseline and cause-directed tests rather than an indiscriminate panel. Escalate immediately if the collection is increasing rapidly or haemodynamic findings are evolving.
  4. For a stable, asymptomatic collection without a high-risk cause or tamponade physiology, agree a cause-based surveillance interval and explicit deterioration advice.
Drain or sampleSelect intervention for a stable effusion

The patient is not in shock but the cause, symptoms, size, trajectory or recurrence may justify intervention.

  1. Arrange diagnostic drainage or tissue when purulent, tuberculous or malignant disease is suspected and the result will direct treatment; do not wait for classic tamponade when source control is needed.
Open full textbook →Answer 2 questionsCardiology check
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • 2025 ESC Guidelines for the management of myocarditis and pericarditisPrimary current source for effusion triage, imaging, drainage, aetiology, malignant and purulent disease, and follow-up.
  • ESC guideline hub: Myocarditis and pericarditisOfficial guideline landing page and supporting material.
  • ESC: Pericardiocentesis in cardiac tamponade—indications and practical aspectsImage-guided drainage indications, procedural planning and specimen principles.
  • Resuscitation Council UK 2025: Adult advanced life supportCurrent UK reversible-cause and peri-arrest framework for tamponade.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Consider therapeutic drainage for a persistent symptomatic large collection, progressive enlargement or clinically important recurrence after balancing procedural access and cause.
  • Choose an image-guided percutaneous catheter when there is a safe fluid window; choose a surgical window or biopsy when fluid is loculated, recurs repeatedly, tissue is required or percutaneous drainage will not achieve source control.
  • Before the procedure, define the specimen plan, anticoagulation and bleeding issues, likely access and post-procedure monitoring. Life-saving drainage should not be withheld solely because correction of coagulopathy is incomplete.